Skip to main content


Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study)

Fig. 1

Study flow chart with percentages disease activity score (DAS) and drug-free remission after the second study year. Orange prednisone, green methotrexate (MTX), dark blue treatment according to opinion of rheumatologist (TAR), aqua hydroxychloroquine (HCQ), yellow sulfasalazine (SSZ), purple adalimumab biweekly, double thickness purple adalimumab weekly, grey protocol not followed as required but remained in follow up (outside of protocol, OOP). DFR drug-free remission

Back to article page